Skip to main content

13 November 2025

Last updated: Thursday 13 November 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Novimmune's antibody strategy attracks investors

Saturday 6 June 2009

Interviewee/Contributor

Luca Bolliger

Organisation

Novimmune SA

Organisations

Molecular Health GmbH
Zelluna Immunotherapy AS
MedImmune
Evernow Publishing Ltd
MaaT Pharma SA
Innovation and International Relationship
Nantes University Hospital
University of Aberdeen
Paul Capital Healthcare
Independent regulatory affairs professional

Interviewees and Contributers

Alan Aubrey
Tore Bengtsson and Sten Van Beek
Johan Strömquist
Cornelis Melief
Johan Strömquist and Thomas Lönngren
Eric Castaldi
Sean Smith, Jeffrey Abbey and Steve Coats
Chris Parker
Morten Grunnet
Ruth McKernan

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Werner Lanthaler appointed CEO of FairJourney Biologics

Thursday 6 November 2025

New CEO at Evaxion

Thursday 6 November 2025

Draig Therapeutics appoints President and CEO

Thursday 6 November 2025

Forbion appoints partner in growth fund

Thursday 6 November 2025

Amphista Therapeutics names executives to drive clinical development

Thursday 6 November 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form